Latest Australian Taxation News

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Careteq Limited signals progress on its 1-System platform integration with a planned Q3 FY26 restart, while Embedded Health Solutions expands aged care contracts and the company navigates a significant ATO R&D tax objection.

Wrkr Ltd has reported a strong start to FY26 with its third consecutive quarter of positive operating cash flow and a successful $15 million capital raise, positioning the fintech for accelerated growth ahead of major client launches.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Ryder Capital Limited has announced a 20% increase in its annual dividend, moving to quarterly payments starting January 2026, enhancing income certainty for shareholders.

333D Ltd reports a fifth consecutive quarter of revenue growth, secures $1 million in fresh capital, and expands its blockchain healthcare initiatives while building a strategic Bitcoin treasury.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for its suite of Australian iShares ETFs for the September 2025 distribution period, alongside important tax certification reminders for investors.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for 14 Australian domiciled iShares ETFs, with payments scheduled for 22 October 2025. Investors are reminded of key dates and tax certification requirements under FATCA and CRS.

Wellard Limited has received a final Australian Taxation Office ruling confirming its recent 15 cents-per-share return of capital is not taxable as a dividend, clarifying the tax implications for shareholders following the sale of its last revenue-generating asset.

BlackRock Investment Management (Australia) Limited has announced estimated cash distributions for a suite of Australian iShares ETFs, outlining key dates and options for reinvestment. Investors are reminded to complete necessary tax certifications ahead of the record date.